Vir Biotechnology, Inc.
US ˙ NasdaqGS ˙ US92764N1028

SecurityVIR / Vir Biotechnology, Inc.
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership2,579,678 shares
Latest Disclosed Value $ 23,107,432
Dimensional Fund Advisors Lp reports 1.71% increase in ownership of VIR / Vir Biotechnology, Inc.

On May 7, 2026 - Dimensional Fund Advisors Lp filed a 13F-HR form disclosing ownership of 2,579,678 shares of Vir Biotechnology, Inc. (US:VIR) valued at $23,113,915 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 2,536,277 shares of Vir Biotechnology, Inc.. This represents a change in shares of 1.71% during the quarter. The current value of the position is $22,623,776 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 2,579,678 43,401 1.71 23,107 51.11 0.0010
2026-02-12 2025-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 2,536,277 -442,594 -14.86 15,292 -10.09 0.0032
2025-11-12 2025-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 2,978,871 -29,084 -0.97 17,009 12.18 0.0036
2025-08-12 2025-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 3,007,955 323,540 12.05 15,161 -12.85 0.0035
2025-05-13 2025-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 2,684,415 768,950 40.14 17,397 23.74 0.0043
2025-02-13 2024-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 1,915,465 703,360 58.03 14,059 54.87 0.0034
2024-11-07 2024-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 1,212,105 574,619 90.14 9,079 60.02 0.0022
2024-08-09 2024-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 637,486 58,360 10.08 5,673 -3.29 0.0015
2024-05-10 2024-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 579,126 110,807 23.66 5,867 24.49 0.0016
2024-02-07 2023-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 468,319 -259,296 -35.64 4,713 -30.87 0.0014
2023-11-09 2023-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 727,615 -295,124 -28.86 6,817 -72.83 0.0022
2023-08-09 2023-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 1,022,739 977,639 2,167.71 25,091 2,291.80 0.0080
2023-05-12 2023-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 45,100 0 0.00 1,049 104,800.00 0.0004
2023-02-09 2022-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 45,100 0 0.00 1 -99.89 0.0003
2022-11-10 2022-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 45,100 -72,279 -61.58 870 -70.89 0.0003
2022-08-12 2022-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 117,379 -494,957 -80.83 2,989 -81.02 0.0011
2022-05-13 2022-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 612,336 291,785 91.03 15,749 17.35 0.0049
2022-02-09 2021-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 320,551 269,069 522.65 13,421 499.15 0.0041
2021-11-12 2021-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 51,482 13,793 36.60 2,240 25.70 0.0007
2021-08-12 2021-06-30 13F VIR BIOTECHNOLOGY COM 92764N102 37,689 -10,381 -21.60 1,782 -27.71 0.0006
2021-05-14 2021-03-31 13F VIR BIOTECHNOLOGY COM 92764N102 48,070 38,200 387.03 2,465 833.71 0.0008
2021-03-08 2020-12-31 13F/A-2 VIR BIOTECHNOLOGY COM 92764N102 9,870 274 2.86 264 -19.76 0.0001
2021-02-11 2020-12-31 13F VIR BIOTECHNOLOGY COM 92764N102 9,870 274 264 95.3428
2020-11-12 2020-09-30 13F VIR BIOTECHNOLOGY COM 92764N102 9,596 9,596 329 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.